Technology transfer
Full Technology Transfer and supply of critical materials for local manufacturing at the partner’s facilities
Our mission
Developed to control the spread of infectious diseases and increase their accessibility through decentralized manufacturing in collaboration with local partners.
BioMARIC develops, manufactures, and distributes high-performance biomaterials and best-in-class in vitro diagnostic devices (RUO) for the detection of human infectious pathogens like HIV, HCV, HTLV, SARS-CoV-2.
Find out more


BioMARIC is a privately owned Belgian biotechnology company founded in 2001, predominantly focusing on prevention and control of infectious diseases.
BioMARIC continuously maintains global collaboration with the third world scientific and medical community on projects that target to slow down the spread of infectious diseases.
Create maximum synergy between different stakeholders to make high quality healthcare products accessible at affordable prices in all countries of the world, in particular the growing economy countries and the countries located in resource-poor parts of the world.
Depending on local market conditions, BioMARIC alliances can be based on several collaborative models:


Full Technology Transfer and supply of critical materials for local manufacturing at the partner’s facilities
Supply of selected critical detection modules developed for specific use in immunoassays
OEM manufacturing of the BioMARIC assay (kit) under the partner’s label
We cooperate with our partners to find the best model for cooperation and create maximum synergy to the benefit of all parties involved, including the local community.
Contact usIn 2019, BioMARIC was awarded the EN ISO 13485:2016 certification, which ensures that our products and services meet the stringent quality standards through an effective quality management system.